Evidence map›Paper›PMID 33159067›Full record

ArticleNature communications2020

Scalable continuous evolution for the generation of diverse enzyme variants encompassing promiscuous activities.

Gordon Rix, Ella J Watkins-Dulaney, Patrick J Almhjell, Christina E Boville, Frances H Arnold, Chang C Liu

Abstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed.

  1. Phage-assisted continuous evolution of enzymes for noncanonical tyrosine biosynthesis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Knowledgeable Language Models as Black-Box Optimizers for Personalized Medicine.... International Conference on Learning Representations · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Bioengineering hybrid artificial life.Frontiers in bioinformatics · 2025
    Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Gordon RixDepartment of Molecular Biology and Biochemistry, University of California, Irvine, CA, USA.
Ella J Watkins-DulaneyDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Patrick J AlmhjellDivision of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, CA, USA.
Christina E BovilleDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Frances H ArnoldDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID 0000-0002-4027-364X
Chang C LiuDepartment of Molecular Biology and Biochemistry, University of California, Irvine, CA, USA. ccl@uci.edu.ORCID 0000-0002-3290-2880

Funding

Diversity Supplement for A High-Throughput Continuous Evolution System for in vivo Biosensor EngineeringDP2GM119163 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI LIU, CHANG C · 2015 to 2017
$2.5M
Development of a Biocatalytic Platform for Convergent Synthesis of Chiral AminesR01GM125887 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ARNOLD, FRANCES H · 2018 to 2021
$1.2M
NIGMS NIH HHS DP2 GM119163NIGMS NIH HHS R01 GM125887
6 · The paper itself

Abstract

Enzyme orthologs sharing identical primary functions can have different promiscuous activities. While it is possible to mine this natural diversity to obtain useful biocatalysts, generating comparably rich ortholog diversity is difficult, as it is the product of deep evolutionary processes occurring in a multitude of separate species and populations. Here, we take a first step in recapitulating the depth and scale of natural ortholog evolution on laboratory timescales. Using a continuous directed evolution platform called OrthoRep, we rapidly evolve the Thermotoga maritima tryptophan synthase β-subunit (TmTrpB) through multi-mutation pathways in many independent replicates, selecting only on TmTrpB's primary activity of synthesizing L-tryptophan from indole and L-serine. We find that the resulting sequence-diverse TmTrpB variants span a range of substrate profiles useful in industrial biocatalysis and suggest that the depth and scale of evolution that OrthoRep affords will be generally valuable in enzyme engineering and the evolution of biomolecular functions.

Indexed as

Bacterial ProteinsBiocatalysisEvolution, MolecularMutationProtein SubunitsSubstrate SpecificityThermotoga maritimaTryptophanTryptophan SynthaseBacterial ProteinsProtein SubunitsTryptophanTryptophan Synthase

Identifiers

PMID33159067
PMCPMC7648111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.